A Pilot Study Assessing EmSam in Bipolar Depression

Phase 4 Terminated 3 enrolled New York State Psychiatric Institute

NaSingle-groupOpen-labelTreatment

Summary

This pilot study will evaluate the efficacy of the monoamine oxidase inhibitor (MAOI)EmSam, a selegiline transdermal system (STS), in bipolar depression.

Timeline

Start: 2007-03
Primary completion: 2012-02
Completion: 2012-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Selegiline	Unknown	—	Other

A Pilot Study Assessing EmSam in Bipolar Depression

Summary

Timeline

Drugs

Indications